MarketCap
Xenetic Biosciences XBIO
$ 1.87
-1.06%
Facebook
X
Telegram
Xenetic Biosciences P/S Ratio | XBIO
Annual P/S Ratio Xenetic Biosciences
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.47 | 1.58 | 2.38 | 0.333 | 8.41 | 34.2 | 252 | - | 2.54 | 11.7 | - | - | - | - | - |
Annual performance
Select metrics to display
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 252 | 0.333 | 35 |
P/S Ratio of other stocks in the Biotechnology industry
| Issuer | P/S Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Neos Therapeutics, Inc.
NEOS
|
1.25 | - | -2.54 % | $ 57.2 M |  USA |
 |
Xencor
XNCR
|
7.1 | $ 36.19 | 6.28 % | $ 2.69 B | USA |
 |
Osmotica Pharmaceuticals plc
OSMT
|
1.47 | - | -10.74 % | $ 89.9 M | USA |
 |
Pandion Therapeutics, Inc.
PAND
|
47.7 | - | - | $ 1.77 B | USA |
 |
Translate Bio, Inc.
TBIO
|
8.85 | - | - | $ 2.81 B | USA |
 |
Trillium Therapeutics Inc.
TRIL
|
7.44 K | - | - | $ 1.94 B |  Canada |
 |
Exicure
XCUR
|
18.8 | $ 0.91 | 2.77 % | $ 5.73 M | USA |
 |
Acceleron Pharma Inc.
XLRN
|
93.1 | - | - | $ 10.9 B | USA |
 |
Zealand Pharma A/S
ZEAL
|
2.92 | - | 0.52 % | $ 821 M |  Danmark |
 |
Zogenix, Inc.
ZGNX
|
74.6 | - | -4.97 % | $ 664 M | USA |
 |
ZIOPHARM Oncology, Inc.
ZIOP
|
2.06 K | - | -7.58 % | $ 264 M | USA |
 |
Xenon Pharmaceuticals
XENE
|
318 | $ 39.02 | 3.56 % | $ 3.09 B | Canada |
 |
Leap Therapeutics
LPTX
|
185 | - | 368.57 % | $ 41.9 M | USA |
 |
Zymeworks
ZYME
|
31.7 | $ 29.63 | 3.1 % | $ 1.53 B | Canada |
 |
ADMA Biologics
ADMA
|
7.41 | $ 12.73 | -3.67 % | $ 3.03 B | USA |
 |
Burford Capital Limited
BUR
|
6.73 | $ 3.6 | -9.22 % | $ 789 M |  Britain |
 |
Daré Bioscience
DARE
|
16.4 | $ 0.64 | 2.96 % | $ 7.15 M | USA |
 |
Fate Therapeutics
FATE
|
28.1 | $ 1.84 | -0.54 % | $ 219 M | USA |
 |
Halozyme Therapeutics
HALO
|
6.91 | $ 103.85 | -15.54 % | $ 12.4 B | USA |
 |
Hutchison China MediTech Limited
HCM
|
21.9 | $ 15.16 | 6.76 % | $ 13 B |  China |
 |
Aptorum Group Limited
APM
|
32.9 | - | - | $ 5.72 M | China |
 |
iBio
IBIO
|
1.42 K | $ 0.74 | 0.77 % | $ 77 M | USA |
 |
Karyopharm Therapeutics
KPTI
|
0.000308 | $ 0.05 | -14.81 % | $ 547 | USA |
 |
FSD Pharma
HUGE
|
172 | - | 5743.5 % | $ 69.7 M | Canada |
 |
BioAtla
BCAB
|
747 | $ 1.74 | 0.64 % | $ 102 M | USA |
 |
Catalyst Pharmaceuticals
CPRX
|
5.16 | - | - | $ 3.85 B | USA |
 |
UroGen Pharma Ltd.
URGN
|
8.41 | $ 24.77 | -3.73 % | $ 1.19 B |  Israel |
 |
Catalyst Biosciences
CBIO
|
8.57 | $ 13.47 | 4.1 % | $ 1.2 B | USA |
 |
Acasti Pharma
ACST
|
0.203 | - | 4.01 % | $ 150 M | Canada |
 |
ADiTx Therapeutics
ADTX
|
11.5 | - | - | $ 374 | USA |
 |
Aeterna Zentaris
AEZS
|
1.54 | - | 5.93 % | $ 314 M | Canada |
 |
AgeX Therapeutics
AGE
|
9.24 | - | -10.17 % | $ 12.2 K | USA |
 |
Aeglea BioTherapeutics
AGLE
|
93.5 | - | - | $ 1.01 B | USA |
 |
AIkido Pharma
AIKI
|
0.935 | - | 1.93 % | $ 17.4 M | USA |
 |
Apellis Pharmaceuticals
APLS
|
2.76 | - | - | $ 5.18 B | USA |